Sylvester Researcher Ifeanyichukwu Ogobuiro Receives Grant to Further Brain Cancer Research
The $50,000 grant from the Radiological Society of North America (RSNA) will support Dr. Ifeanyichukwu Ogobuiro's innovative research into radiation resistance in glioblastoma (GBM).
About the role
Dr. Ogobuiro, a resident physician at Sylvester Comprehensive Cancer Center, will use the grant to explore the CNS-specific protein BRI3, which has emerged as a potential driver of radiation resistance in GBM.
Responsibilities
- Explore how BRI3 controls genes that protect cancer cells from radiation
- Investigate if targeting BRI3 in preclinical models can improve tumor response to treatment
Qualifications
Dr. Ogobuiro’s research focuses on BRI3, a protein that has shown promise in understanding GBM resistance to radiation. His background in radiation oncology and his mentorship from Markus Bredel, a Sylvester professor, provide strong support for his work.
Benefits
The grant includes an opportunity for Dr. Ogobuiro to present his findings at the RSNA 111th Scientific Assembly and Annual Meeting in Chicago, and to pursue his doctoral degree in cancer biology while working on the grant proposal.
Pay
The grant provides a one-year, $50,000 stipend to support Dr. Ogobuiro's research.
Schedule
Dr. Ogobuiro will have protected time to complete his doctoral degree during the Holman Physician-Scientist Pathway, starting this summer.